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Abstract
Background: Probiotic bacteria are thought to play an important role in the digestive system and
therefore have to survive the passage from stomach to intestines. Recently, a novel approach to
simulate the passage from stomach to intestines in a single bioreactor was developed. The
advantage of this automated one reactor system was the ability to test the influence of acid, bile
salts and pancreatin.
Lactobacillus gasseri K7 is a strain isolated from infant faeces with properties making the strain
interesting for cheese production. In this study, a single reactor system was used to evaluate the
survival of L. gasseri K7 and selected bifidobacteria from our collection through the stomach-
intestine passage.
Results: Initial screening for acid resistance in acidified culture media showed a low tolerance of
Bifidobacterium dentium for this condition indicating low survival in the passage. Similar results were
achieved with B. longum subsp. infantis whereas B. animalis subsp. lactis had a high survival.
These initial results were confirmed in the bioreactor model of the stomach-intestine passage. B.
animalis subsp. lactis had the highest survival rate (10%) attaining approximately 5 × 106 cfu ml-1
compared to the other tested bifidobacteria strains which were reduced by a factor of up to 106.
Lactobacillus gasseri K7 was less resistant than B. animalis subsp. lactis but survived at cell
concentrations approximately 1000 times higher than other bifidobacteria.
Conclusion: In this study, we were able to show that L. gasseri K7 had a high survival rate in the
stomach-intestine passage. By comparing the results with a previous study in piglets we could
confirm the reliability of our simulation. Of the tested bifidobacteria strains, only B. animalis subsp.
lactis showed acceptable survival for a successful passage in the simulation system.
Background
Probiotics, especially lactic acid bacteria have beneficial
effects on consumers health as suggested in 1907 [1]. It
was believed that bacteria mainly controlled infections
caused by enteric pathogens and regulated toxoaemia,
thereby improving health and influencing mortality.
Meanwhile it has been known that some of the positive
effects on consumers health are the improvement in the
Published: 8 May 2009
BMC Microbiology 2009, 9:87 doi:10.1186/1471-2180-9-87
Received: 17 December 2008
Accepted: 8 May 2009
This article is available from: http://www.biomedcentral.com/1471-2180/9/87
© 2009 Ritter et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 9
(page number not for citation purposes)
BMC Microbiology 2009, 9:87 http://www.biomedcentral.com/1471-2180/9/87microflora balance in the gut, the stimulation of the
immune system, and aiding the organism to fight patho-
genic microorganisms [2]. A large part of interest was con-
centrated on the use of strains of the genera Lactobacillus
and Bifidobacterium, even if there are also other bacteria
with probiotic effects, e.g. some propionibacteria.
The above mentioned properties are also the basis for a
microorganism to be labelled probiotic. There are differ-
ent definitions worldwide but they are similar in content.
One of the criteria for a probiotic strain is its resistance to
acidity and gastric solutions in the human gastrointestinal
tract [3]. It is therefore important, to evaluate the resist-
ance of a potential probiotic strain to the acidic and gastric
environment in the intestine.
Because of high costs and ethical as well as safety regula-
tions for clinical studies, screening survival is easier to
simulate in vitro. A simple test is to incubate the bacterial
cells in acidic or bile salt solutions for a defined period
and count the number of surviving cells. In a further step,
the simulation is carried out in agitated flasks, combining
acidity and gastric solutions followed by an estimation of
surviving cells over the entire simulation. This is a more
realistic replication of the conditions in the intestine [4].
Another system, the Simulator of the Human Intestinal
Microbial Ecosystem (SHIME), consists of 5 to 6 serially
connected pH controlled bioreactors [5-7]. The setup is
quite complex and demands absolute anaerobic condi-
tions. Furthermore, the absorption of metabolites and
water is not simulated. This was overcome by using dialy-
sis membranes as described by Marteau et al. [8].
Recently, a new system using a single bioreactor was
developed to study the stomach-intestine passage [9]. The
system allowed the pH to be altered inside a single reactor
and was adapted to the retention times in the different
regions of the stomach-intestine passage.
Lactobacillus gasseri K7 was recently isolated from infant
faeces [10]. It produces a bacteriocin which is active
against Clostridium sp. and their spores. L. gasseri belongs
to the so called "acidophilus"-group and several inde-
pendent studies identified these strains as inhabitants of
the skin and intestine [11-13]. In previous experiments, it
has already been shown in vitro that L. gasseri K7 survived
in an acidic environment and with 0.3% bile salts [10].
These findings make the strain interesting as a possible
probiotic.
In this study, a single bioreactor system based on the work
of Sumeri et al. [9] was used to evaluate the survival of
Lactobacillus gasseri K7 and eight Bifidobacterium strains
from our collection. We were able to compare the results
for L. gasseri K7 with a study performed in piglets [14]
which allowed the assessment of a correlation between
the in-vitro study with results from in-vivo experiments.
The retention times and pH used in this study were based
on data from the literature. Several methods exist for
measuring the pH in the intestine [15]. Table 1 shows the
pH values in the different parts of the intestine as meas-
ured by the Heidelberg capsule [16,17]. Retention times
can be calculated either by using marker substances
(chemical) or by radio telemetry capsules such as the Hei-
delberg capsule [18]. However, capsules usually have
longer retention times than chemical markers. Table 2
lists some of the retention times found in the literature
[4,5,19-24].
Based on the data found in the literature and the work by
Sumeri et al. [9] the fermentation process was set up as




The aim of an initial series of tests was to obtain an over-
view of the acid resistance of eight bifidobacteria strains.
Figures 2, 3 and 4 show the survival of these strains using
contour plots made with Sigmaplot. Bifidobacterium den-
tium (Figure 3) showed the least acid resistance. Between
pH 4.0 and pH 2.0 there was no difference in survival and
the concentration of cells dropped by more than 7 log
within 40 minutes. Bifidobacterium animalis subsp. lactis
was more resistant up to 40 min at pH 2.0, but then
decreased by about 3 log when incubated for 120 minutes
(Figure 4). At a pH between 2.5 and 3.0 the decrease was
less than 1 log after 120 minutes.
All the other tested Bifidobacterium strains (B. longum, B.
breve, B. longum subsp. infantis and B. adolescentis)
showed a similar but different pattern from B. animalis
subsp. lactis (Figures 2, 3 and 4). They had a short survival
time below pH 2.5 and survived in higher numbers above
pH 3.5.
With the aim of developing a method to simulate the GI
in the bioreactor, a further test was done with one strain.
To observe the influence of a food matrix, concentrated B.
longum subsp. infantis was resuspended in skim milk
Table 1: pH values in the human intestinal tract, measured with 
the Heidelberg capsule.
Stomach Duodenum Jejunum Ileum
proximal medial Distal
pH 1.4** 6.22* 6.4** 7.1** 7.4**
* Fallingborg et al. 1994 [16]
** Fallingborg et al. 1998 [17]Page 2 of 9
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right-hand column of Figure 5, milk had a direct effect on
the survival of the strain. Between pH 3.0 and 3.5 the bac-
teria survived for 120 min with a reduction of log 2. Below
pH 3.0 the survival rate decreased to about log 5. The
decrease in survival below pH 3.0 was rapid but regular
over time. At pH 3.5 and above, the strain was resistant for
at least 120 minutes.
The left-hand column of Figure 5 shows the same strain
without added skim milk. At a pH above 3.5, there was no
influence on the survival of the bacteria. However, below
pH 3.5 the survival decreased depending on the duration
of incubation. Between pH 3.0 and 3.5 the strain had
already decreased by about log 5. After 30 min incubation,
there was almost a linear decrease in survival with decreas-
ing pH from 3.0 to 2.5.
Simulation in the bioreactor
Most systems described in the literature consist of several
reaction vessels, e.g. the SHIME [6]. Other studies used
immobilized cells with three reactors [25] or a dialysis sys-
tem [8]. Based on the work of Sumeri et al. [9] and the col-
lected data of the conditions in the intestinal passage we
were able to limit the simulation to one vessel. Together
with the data from the acid resistance screening, the selec-
tion of a possible starting pH and broth composition in
the simulator could be chosen. The resulting simulation
parameters are shown in Figure 1 and described in the
Material and Methods section. During the experimental
stage of this study, Sumeri et al. [9] developed a similar
system to evaluate Lactobacillus sp. in a stomach-intestine
passage simulation.
The software package "Lucullus" was an excellent tool to
control the pH and the process according to the developed
simulation. Selecting the medium in the bioreactor was
simplified by choosing the corresponding growth
medium for the strains, supplemented with skim milk,
functioning as a simulated food matrix. Afterwards, it was
acidified to the starting pH and supplemented with
enzyme solutions as described in Materials and Methods.
The simulations were carried out serially, one per day. The
results are shown in Figure 6. The strains used for the sim-
ulation are listed in table 3 (only Bifidobacterium dentium
was excluded) and were standardized to an OD650 of 1.5
prior to inoculation.
Bifidobacterium adolescentis was inoculated as described
above at an initial concentration of 107 cfu ml-1 and
decreased almost linearly to below 104 cfu ml-1 after 5
hours. B. breve and B. longum strains had an initial concen-
tration between 107 and 108 cfu ml-1 and diminished to
below 102 cfu ml-1 within the first 30 minutes. B. animalis
subsp. lactis 14403 survived to approximately 15% of the
initial average cfu of 5 × 108 cfu ml-1. There was a rapid
decrease in survival of B. longum subsp. infantis over the
first 30 min. Afterwards the survival decreased only slowly
from 105 to 104 cfu ml-1.
In a later phase, Lactobacillus gasseri K7 was included in the
study since several projects were running at this time at
our institute with this strain. Lactobacillus gasseri K7 was
inoculated at 2.2 × 107 cfu ml-1 and after 7 h simulation a
concentration of 105 cfu ml-1 living cells was still present
in the culture media (Figure 7, curve for 250 ml pre-cul-
ture). The highest reduction in survival was within the first
2 hours and began immediately after the addition of gas-
tric juice and bile salts. Within this time, there was a
Parameters of the stomach-intestinal passage simulation over 7 hFigur  1
Parameters of the stomach-intestinal passage simu-
lation over 7 h.
Table 2: Retention times in the small intestine cited in literature.
Retention time Source Remarks
1–4 h Huang and Adams 2004 [21]
4.25 h Van Den Driessche et al. 2000 [24] Stomach and small intestine
4 h Mojaverian 1996 [22]
6 h Picot and Lacroix 2004 [4] Selected maximum time of the simulation
7.5 h Fallingborg et al. 1990 [20] Children
8 h Fallingborg et al. 1989 [19]
8 h Alander et al. 1998 [5] Simulation in the SHIME Reactor
6–10 h Thews et al. 1991 [23]Page 3 of 9
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simulation time, there was only a log 1 reduction of living
cells.
The preparation of the inoculum of L. gasseri K7 in a 100
ml culture volume was also evaluated. The results of the
experiments are shown in Figure 7. With 250 ml culture
the decrease in living cells was about log 2 whereas the
decrease with a 100 ml culture was only log 1 over the
whole incubation time. However, 2 h after addition of
bile salts and pancreatic juice, the decrease in cell counts
was similar for both volumes.
Discussion
When harvesting a culture after a given incubation time,
the growth phase of each bacterial strain can be different
since all have different growth dynamics. In order to
obtain cells at approximately the same growth phase, pre-
liminary experiments were performed (data not shown).
An incubation time of 15 h for the pre-culture was suita-
ble for all tested strains except Bifidobacterium longum
subsp. infantis which needed to be incubated for only 12
h.
The acid tolerance screening (Figures 2, 3 and 4) was per-
formed to evaluate the effect of pH independently of other
conditions. Bifidobacterium dentium was highly sensitive to
acid and therefore would possibly not survive the passage
through the stomach. The strain was therefore not
included in the simulation experiments. The B. longum
strains (Figure 2) did not yield much better results than B.
Acid resistance of three Bifidobacterium longum strainsFigu  2
Acid resistance of three Bifidobacterium longum strains. X-axis: time (min); Y-axis: pH; log cfu are shown in colour 
(scale on the right of the graphs). Numbers in the bacterial names are the strain numbers in the FAM-database of ALP.
Acid resistance of Bifidobacterium dentium, B. longum subsp. infantis and B. adolescentisFigu  3
Acid resistance of Bifidobacterium dentium, B. longum subsp. infantis and B. adolescentis. X-axis: time (min); Y-axis: 
pH; log cfu are shown in colour (scale on the right of the graphs). Numbers in the bacterial names are the strain numbers in 
the FAM-database of ALP.Page 4 of 9
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Acid resistance of Bifidobacterium breve and B. animalis subsp. lactisFigu  4
Acid resistance of Bifidobacterium breve and B. animalis subsp. lactis. X-axis: time (min); Y-axis: pH; log cfu are shown 
in colour (scale on the right of the graphs). Numbers in the bacterial names are the strain numbers in the FAM-database of 
ALP.
Comparison of acid resistance of Bifidobacterium longum subsp. infantis 14390 suspended in NaCl or skim milkFigure 5
Comparison of acid resistance of Bifidobacterium longum subsp. infantis 14390 suspended in NaCl or skim milk. 
Left: Bifidobacteria resuspended in NaCl, right: Bifidobacteria resuspended in milk. X-axis: time (min); Y-axis: pH; log cfu are 
shown in colour (scale on the right of the graphs). Numbers in the bacterial names are the strain numbers in the FAM-database 
of ALP.
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more resistant than B. dentium.
B. longum subsp. infantis is one of the first species to pop-
ulate the human intestine shortly after birth [26]. Based
on the experiments in this study, however, the tested B.
longum subsp. infantis strain would only be able to pass
the infant stomach in high numbers if the transition time
in the acidic stomach was very short. The survival of the
selected strain in the tested environment was too low for
successful passage in high numbers. When the strain was
resuspended in skim milk, survival increased (Figure 5).
This could be an indication that human milk helps B.
longum subsp. infantis strains to pass the stomach-intes-
tine passage with at a higher survival rate.
The protective effects of milk proteins in the digestive sys-
tem have already been described in the literature [27].
Protection with milk proteins has also been shown in this
study (Figure 5). With the appropriate matrix or even a
carrier, probiotic bacteria could safely pass through the
stomach to the intestines to reach their site of action.
B. adolescentis strains that populate the human intestine at
a later age, had slightly higher resistance than B. longum
subsp. infantis which may explain the reduction of the lat-
ter during the progress of the human infant to adulthood
[26].
The most interesting strain was B. animalis subsp. lactis,
which was the least sensitive strain in our study. This pH-
resistant strain has a great potential for use in foods as a
probiotic supplement since a higher number of bacterial
cells would survive the passage. However, to use this
strain as probiotic, more studies have to be performed in
order to achieve the probiotic status according to the def-
inition of Klaenhammer [3].
In our study, the ingestion of a food matrix was simulated
in an initial environment of acidified milk and growth
medium. The added simulated gastric solution and oxy-
gen during the stomach phase increased the stress. During
the simulated passage to the small intestine the oxygen
was replaced by nitrogen and the medium was neutralized
to pH 6.3. The addition of the pancreatic solution and bile
salts completed the passage into the small intestine. This
in-vitro system did not take into account that in in vivo
digestion, enzymes are activated and inactivated and
other substances, e.g. bile salts are reabsorbed. Sumeri et
al. [9] found a partial solution to bypass this problem.
They diluted the content of the reactor with a specially
designed dilution medium. Another possibility would be
to precipitate the bile salts at the end of simulation of the
small intestine to imitate the enterohepatic circuit. This
could be performed with calcium ions [28-30]. Removing
the bile salts would better simulate the environment of
the colon and might even allow bifidobacteria to prolifer-
ate.
In our study, the remaining bile salts and pancreatic juice
in the simulation led to an additional stress on bacteria
which probably altered the true characteristics of the
strains in vivo.
The starting cfu in the simulation varied within one log
cfu even though the adjustment of OD650 of the inoculum
Development of 7 Bifidobacterium strains during stomach-intestinal passage simulation for 7 hFigure 6
Development of 7 Bifidobacterium strains during 
stomach-intestinal passage simulation for 7 h. Dashed 
line shows the time of addition of bile salts and pancreatic 
juice. Numbers in the bacterial names are the strain numbers 
in the FAM-database of ALP.
Table 3: Strains tested in the simulation.
Name Identification number of ALP strain collection
Bifidobacterium adolescentis FAM-14377
Bifidobacterium breve FAM-14398
Bifidobacterium longum subsp. infantis FAM-14390
Bifidobacterium animalis subsp. Lactis FAM-14403
Bifidobacterium dentium FAM-14396
Bifidobacterium longum FAM-14382, -14383, -14406
Lactobacillus gasseri K7 FAM-14459Page 6 of 9
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subsp. lactis and Bifidobacterium longum subsp. infantis
strains. The bifidobacteria used in this study showed a ten-
dency to form clusters that may result in reduced cfu (vis-
ual observations, data not shown). In another study, the
formation of clusters could be related to decreasing pH
during growth [31]. These clusters are usually counted as
one colony on a plate.
Figure 6 shows the results of the stomach-intestine pas-
sage simulation over 7 h of seven tested Bifidobacterium
strains. The concentration of living cells of bifidobacteria
decreased immediately after incubation due to the low pH
(pH 3.0). However, B. animalis subsp. lactis remained sta-
ble. This confirmed the results of previous experiments
discussed above (Figure 4). This resistance could be
extended to bile salts and pancreatic juice although the
cell counts of B. animalis subsp. lactis decreased by about
85% of the initial value (Figure 6). Compared to the other
strains used in this study, however, this decrease was
almost negligible.
All B. longum and B. breve strains died very rapidly at the
beginning of the simulation and were below the detection
limit of the plating method within a few hours (Figure 6)
which was to be expected from the results of the screening
experiment above (Figures 2 and 4).
On the other hand, B. longum subsp. infantis 14390
decreased rapidly at the beginning of simulation but after
the addition of pancreatic juice and bile salts and a change
to an anaerobic environment, the reduction rate
decreased. Our study suggests that this strain is well
adapted to the conditions in the intestine but needs to be
ingested in high numbers to survive the conditions in the
stomach (oxygen, low pH). As mentioned above, B.
longum subsp. infantis strains belong to the first group of
bacteria populating the intestine of infants [26].
In contrast to B. longum subsp. infantis, B. adolescentis
decreased almost linearly during the 7 h simulation. There
was no detectable interruption when the conditions in the
fermenter changed. Based on the experiments for the acid
tolerance screening, this result was unexpected.
However, this might be related to the testing conditions
where the bile salt and gastric juice concentrations
remained at the initial level and were not diluted as they
would be in vivo. In a future experiment, it should be eval-
uated whether the dilution method developed by Sumeri
et al. [9] would stabilize the cell counts of B. adolescentis
during the 6 h simulation period in the intestine.
In our study, we also evaluated the stomach-intestine pas-
sage of Lactobacillus gasseri K7. The strain has already been
evaluated for survival in vivo in piglets [14]. Therefore, it
was possible to compare our in-vitro results with data from
in vivo experiments.
Bogovic et al. [14] fed piglets over a period of 14 days with
5*1010 cfu day-1 of L. gasseri K7. This resulted in approx.
7*104 cfu g-1 in the faeces during the feeding period. It has
to be taken into account that the concentration of bacteria
was diluted before it finally arrived at the stomach-intes-
tine passage. In a rough approximation, we estimated that
about 1% arrived at the passage. This allowed us to com-
pare the results of this piglet study with the end of our
simulation.
As shown in Figure 5, L. gasseri K7 had a cell concentration
of approximately 5*104 cfu ml-1 after the 7 h simulation
period (with a pre-culture of 250 ml) which is similar to
the concentration in the faeces of the piglets. This suggests
that the simulation model used in this study could be a
helpful tool to estimate the effects of the passage in an in-
vitro model prior using expensive in vivo models. The
model could be further optimized by diluting the bile
salts and pancreatic juice as described by Sumeri et al. [9].
To simulate the activation and deactivation of enzymes a
suitable method has still to be found.
When only 100 ml medium was used for the inoculum of
L. gasseri K7, the culture survived the simulation better
Comparison of the influence of 100 ml pre-culture of Lacto-bacillus gasseri K7 w th 250 ml pre-cultureFigure 7
Comparison of the influence of 100 ml pre-culture of 
Lactobacillus gasseri K7 with 250 ml pre-culture. The 
pre-culture was harvested by centrifugation and resuspended 
in physiological sodium chloride solution to achieve an OD600 
of 1.5. The stomach-intestinal passage simulation was incu-
bated using the adjusted solution and incubated for 7 h. The 
dashed line shows the addition of bile salts and pancreatic 
juice. Curves are the mean of duplicate experiments.Page 7 of 9
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Both volumes were inoculated by 1 ml. Therefore, the cul-
ture with 250 ml volume was in an earlier stage of growth
than the 100 ml culture. These results were an indication
of the growth phase dependency of the culture for during
stress.
Conclusion
In this study, we were able to show that the system to sim-
ulate the stomach-intestine passage developed by Sumeri
et al. [9] was suitable for the assessment of survival of 8
Bifidobacterium strains and Lactobacillus gasseri K7 even
though we did not simulate the removal of gastric juice
and bile salts. For L. gasseri K7 we were able to compare
the results with an in-vivo study on piglets and obtained
similar results.
The single reactor system presented here allows a more
straightforward identification of the ideal growth phase
for any possible probiotic strain which is required to pass
the stomach-intestine passage than if it had to be per-
formed with other systems with a difficult setup.
The study also showed that all tested Bifidobacterium
strains, except for B. animalis subsp. lactis, would require
protective agents to survive the passage through the stom-
ach-intestine in high numbers. This could be done using
an appropriate food matrix or encapsulation of the cells.
Methods
Bacterial strains
All bifidobacteria strains were selected from the strain col-
lection of Agroscope Liebefeld-Posieux ALP Research Sta-
tion Switzerland, isolated by ALP from human sources.
Lactobacillus gasseri K7 originated from the ZIM Collection
of Industrial Microorganisms of University of Ljubljana,
Biotechnical Faculty (ZIM 105) [10] and was also depos-
ited in the ALP strain collection. The tested strains and
their identification numbers of the ALP strain collection
are listed in table 3. All bifidobacteria strains are the prop-
erty of ALP.
Media and growth conditions
For pre-cultures, 1 ml frozen conserves of the strains were
inoculated in 250 ml Wilkins-Chalgren broth (WC
CM0643, Oxoid, Hampshire, UK) supplemented with 9 g
l-1 additional lactose-monohydrate (Bifidobacteria) or De
Man-Rogosa-Sharpe (MRS; Biolife, Milano, Italy)
medium (Lactobacillus gasseri K7) [32]. For L. gasseri K7, a
trial with a 100 ml pre-culture was also performed. All
strains, except Bifidobacterium longum subsp. infantis, were
incubated at 37°C for 15 hours under anaerobic condi-
tions. Bifidobacterium longum subsp. infantis was incubated
for 12 h since it was very sensitive to extended incubation
periods. The pre-cultures were centrifuged for 15 min at
3500 rpm and the pellets resuspended in 10 ml of phos-
phate-buffered physiological sodium chloride solution
(PBS).
Determination of cell count
The cell count was determined by 10-fold serial dilution
of the culture in physiological saline solution. The two
highest dilutions were then plated on MRS agar (Biolife,
Milano, Italy) using a spiral plater (IUL Instruments,
Barçelona, Spain) and evaluated by an automated colony
counter with the corresponding software (IUL Instru-
ments, Barçelona, Spain).
Screening for acid resistance
For the acid resistance screening the concentrated cell sus-
pension from the pre-culture was pipetted into 20 ml of
PBS until an OD650 of 1.0 was reached. 4 ml of this cell
suspension were then inoculated in 16 ml of citrate-HCl
buffer (tri-Na-Citratex2 H2O 7.35 g and 250 ml distilled
H2O, adapted to the corresponding pH with 1 M HCl) at
pHs of 2.0, 2.5, 3.0, 3.5 and 4.0. The incubation was done
at 37°C and samples were taken every 30 min over 120
min. 1 ml of samples were mixed with 9 ml 0.25 M phos-
phate buffer at pH 7.0 at the first step of the dilution
series. For the acid resistance test in a food matrix, the
same amount of pre-culture as used above (adjusted to an
OD650 of 1.0) was pipetted into 20 ml of UHT skim milk.
4 ml of this cell suspension in milk were inoculated into
16 ml of citrate-HCl buffer. All chemicals were purchased
from Merck (Darmstadt, Germany). The data for the
screening experiments was visualized in contour plots
using the Sigmaplot 11.0 software (Systat Software Inc.,
Chicago IL, USA).
Simulation in the bioreactor
All solutions were freshly prepared for each experiment.
Simulated stomach solution was made of 50 mg pepsin
porcine gastric mucosa (Sigma-Aldrich P7012, Buchs,
Switzerland) in 20 ml of 0.1 M HCl. For the simulated
pancreatic juice 2 g pancreatin (Sigma-Aldrich P7545)
were dissolved in 50 ml of 0.02 M phosphate buffer at a
pH of 7.5. Simulated bile salt solution was made of 7.5 g
bovine bile (Sigma-Aldrich B3883) made up to 50 ml
with distilled H2O. The broth for the simulation was
either 1 l WC or MRS broth with 29.41 g tri-sodium
citratex2 H2O. During testing of survival in a food matrix,
500 ml of UHT skim milk were added and the pH
adjusted to 3.0 with 5 M HCl shortly before the simula-
tion. 1 l medium was added to the bioreactor (NewMBR
Mini, NewMBR, Switzerland), previously sterilized with
water (121°C, 20 min), and heated to 37°C. During the
stomach simulation, aeration was implemented. The fer-
mentation was controlled and recorded using the inte-
grated process management software Lucullus
(Biospectra, Schlieren, Switzerland). The concentrated cell
suspension from the pre-culture was pipetted into 40 ml
of PBS to an OD650 of 1.5. Shortly before the inoculationPage 8 of 9
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solution was added to the medium (1 l) in the bioreactor.
The pH was adjusted using 2 M NaOH.
Sixty minutes after the inoculation of the cells, the oxygen
was replaced by nitrogen to obtain an anaerobic atmos-
phere. This was performed by flushing the headspace and
making the system air-tight. After attaining a pH of 5.0
(after approx. 1 h fermentation time), 34 ml of the bile
salt solution and 50 ml pancreatic juice were inoculated.
Samples were taken every 20 minutes during the first hour
and then only every 60 minutes. The total simulation time
was set to 7 hours with an average stomach pH of 3.0. The
time in the stomach was set to one hour, followed by
rapid neutralization to 6.3 and a slow increase to 7.5 over
the remaining 5 hours and 40 minutes (Figure 1).
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